Atabecestat is a Brain-Penetrant and Orally Active BACE1 Inhibitor
In general, Alzheimer's disease (AD) exhibits as a neurodegenerative disorder characterized by progressive memory loss and cognitive decline. The neuropathologic hallmarks of AD are extracellular plaques of insoluble amyloid β…